A case of paroxysmal sympathetic hyperactivity in lissencephaly caused by <i>TUBA1A</i> variant

DOI
  • Kobayashi Emiko
    Department of Pediatrics, Gifu Prefectural General Medical Center, Gifu
  • Akaza Kanami
    Department of Pediatrics, Gifu Prefectural General Medical Center, Gifu
  • Ozaki Masato
    Department of Pediatrics, Gifu Prefectural General Medical Center, Gifu
  • Kato Mitsuhiro
    Department of Pediatrics, Showa University School of Medicine, Tokyo Epilepsy Medical Center, Showa University Hospital, Tokyo
  • Saitsu Hirotomo
    Department of Biochemistry, Hamamatsu University School of Medicine, Shizuoka
  • Nakajima Mitsuko
    Department of Biochemistry, Hamamatsu University School of Medicine, Shizuoka
  • Watanabe Kazuki
    Department of Biochemistry, Hamamatsu University School of Medicine, Shizuoka
  • Imamura Atsushi
    Department of Pediatrics, Gifu Prefectural General Medical Center, Gifu

Bibliographic Information

Other Title
  • Paroxysmal sympathetic hyperactivityを認めた<i>TUBA1A</i>遺伝子異常による滑脳症の1例

Abstract

<p>  We report a case of lissencephaly with a new variant in TUBA1A (p.(Ala281Val)) complicated with paroxysmal sympathetic hyperactivity (PSH) characterized by recurrent paroxysmal hypertonia, tachycardia, and elevated body temperature. Using Baguley’s excitatory : inhibitory ratio model, we considered the PSH had occurred due to impairment of the central autonomic network, as the cerebral cortex was thin and the deep white matter was almost absent. PSH is associated with extensive brain damage such as head trauma and hypoxic encephalopathy ; however, the present case expands causal variability to brain malformations. Administration of gabapentin (GBP), a GABA agonist, was effective to control PSH. We considered the PSH was suppressed by GBP which reduced non-nociceptive influx stimuli in spinal cord, affected as a GABA agonist to enhance inhibitory input in brain and spinal cord, and eventually weakened efferent input to sympathetic and motor nerves. In order to elucidate the pathogenesis of PSH associated with cerebral dysplasia and to establish therapeutic strategies, it is necessary to accumulate the same cases.</p>

Journal

  • NO TO HATTATSU

    NO TO HATTATSU 56 (2), 130-133, 2024

    The Japanese Society of Child Neurology

Details 詳細情報について

  • CRID
    1390017965055108736
  • DOI
    10.11251/ojjscn.56.130
  • ISSN
    18847668
    00290831
  • Text Lang
    ja
  • Data Source
    • JaLC
  • Abstract License Flag
    Disallowed

Report a problem

Back to top